VanEck Pharmaceutical 

$104.16
119
-$0.47-0.45% Thursday 20:00

Statistics

Day High
104.76
Day Low
103.51
52W High
112.58
52W Low
77.67
Volume
172,176
Avg. Volume
451,936
Mkt Cap
0
P/E Ratio
-
Dividend Yield
2.07%
Dividend
2.15

Upcoming

Dividends

2.07%Dividend Yield
Apr 26
$0.84
Dec 25
$0.31
Oct 25
$0.39
Jul 25
$0.61
Apr 25
$0.52
10Y Growth
5.4%
5Y Growth
11.51%
3Y Growth
8.21%
1Y Growth
17.42%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PPH. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
iShares U.S. Pharmaceuticals
IHE
Mkt Cap0
IHE is the iShares U.S. Pharmaceuticals ETF, directly competing with PPH by investing in U.S. pharmaceutical companies, making it a close competitor in the pharmaceutical investment space.
State Street SPDR S&P Pharmaceuticals
XPH
Mkt Cap0
XPH is the SPDR S&P Pharmaceuticals ETF, which tracks a similar index of pharmaceutical companies as PPH, offering investors exposure to the pharmaceutical sector.
Invesco Pharmaceuticals
PJP
Mkt Cap0
PJP is the Invesco Dynamic Pharmaceuticals ETF, which competes by using a dynamic investment strategy focused on the pharmaceutical industry, similar to PPH's focus.
Fidelity MSCI Health Care Index
FHLC
Mkt Cap0
FHLC is the Fidelity MSCI Health Care Index ETF, which includes pharmaceutical companies within its broader health care sector focus, competing for the same investment dollars.
Vanguard Health Care
VHT
Mkt Cap0
VHT is the Vanguard Health Care ETF, which, while broader than PPH, still competes by offering significant exposure to the pharmaceutical industry within its health care sector investments.
State Street Health Care Select Sector SPDR
XLV
Mkt Cap0
XLV is the Health Care Select Sector SPDR Fund, which competes by investing in health care and pharmaceutical companies, offering an alternative to PPH's pharmaceutical focus.
iShares U.S. Healthcare
IYH
Mkt Cap0
IYH is the iShares U.S. Healthcare ETF, which includes pharmaceutical companies in its portfolio, competing with PPH for investors looking for health care and pharmaceutical exposure.
VanEck Biotech
BBH
Mkt Cap0
BBH is the VanEck Biotech ETF, which, while focused on biotech, competes with PPH due to the overlap between biotech and pharmaceutical industries.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
FBT is the First Trust NYSE Arca Biotechnology Index Fund, another biotech-focused ETF that competes with PPH because of the close relationship between the biotech and pharmaceutical sectors.
iShares Biotechnology
IBB
Mkt Cap0
IBB is the iShares Biotechnology ETF, which competes with PPH by offering exposure to biotech firms, some of which are involved in pharmaceuticals, thus attracting similar investment interest.

About

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Show more...
CEO
Country
US
ISIN
US92189F6925

Listings

0 Comments

Share your thoughts

FAQ

What is VanEck Pharmaceutical stock price today?
The current price of PPH is $104.16 USD — it has decreased by -0.45% in the past 24 hours. Watch VanEck Pharmaceutical stock price performance more closely on the chart.
What is VanEck Pharmaceutical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange VanEck Pharmaceutical stocks are traded under the ticker PPH.
Is VanEck Pharmaceutical stock price growing?
PPH stock has risen by +3.16% compared to the previous week, the month change is a -4.07% fall, over the last year VanEck Pharmaceutical has showed a +17.18% increase.
Does VanEck Pharmaceutical pay dividends?
Yes, PPH dividends are paid quarterly. The last dividend per share was 0.31 USD. As of today, Dividend Yield (FWD)% is 2.07%.
When did VanEck Pharmaceutical complete a stock split?
The last stock split for VanEck Pharmaceutical was on February 14, 2012 with a ratio of 2:1.